These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12515289)

  • 1. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.
    Hayakawa N; Premawardhana LD; Powell M; Masuda M; Arnold C; Sanders J; Evans M; Chen S; Jaume JC; Baekkeskov S; Smith BR; Furmaniak J
    Autoimmunity; 2002 Aug; 35(5):343-55. PubMed ID: 12515289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.
    Ziegler B; Augstein P; Lühder F; Northemann W; Hamann J; Schlosser M; Klöting I; Michaelis D; Ziegler M
    Diabetes Res; 1994; 25(2):47-64. PubMed ID: 7544254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
    Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
    Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
    Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
    Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodies.
    Tree TI; Morgenthaler NG; Duhindan N; Hicks KE; Madec AM; Scherbaum WA; Banga JP
    Diabetologia; 2000 Jul; 43(7):881-9. PubMed ID: 10952461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.
    Padoa CJ; Banga JP; Madec AM; Ziegler M; Schlosser M; Ortqvist E; Kockum I; Palmer J; Rolandsson O; Binder KA; Foote J; Luo D; Hampe CS
    Diabetes; 2003 Nov; 52(11):2689-95. PubMed ID: 14578287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
    Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
    Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
    Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
    Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and functional characterization of recombinant GAD65 autoantibodies derived by IgG repertoire cloning from patients with type 1 diabetes.
    Jury K; Söhnlein P; Vogel M; Richter W
    Diabetes; 2001 Sep; 50(9):1976-82. PubMed ID: 11522662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the islet cell antibody pattern of monoclonal glutamic acid decarboxylase antibodies recognizing linear and conformational epitopes.
    Augstein P; Schlosser M; Ziegler B; Hahmann J; Mauch L; Ziegler M
    Acta Histochem; 1996 Apr; 98(2):229-41. PubMed ID: 8739307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
    Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
    J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera.
    Tong JC; Myers MA; Mackay IR; Zimmet PZ; Rowley MJ
    Ann N Y Acad Sci; 2002 Apr; 958():182-9. PubMed ID: 12021103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity of the antibody response to GAD65 in Type I diabetes.
    Gilliam LK; Binder KA; Banga JP; Madec AM; Ortqvist E; Kockum I; Luo D; Hampe CS
    Clin Exp Immunol; 2004 Nov; 138(2):337-41. PubMed ID: 15498046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation-dependent GAD65 autoantibodies in diabetes.
    Luo D; Gilliam LK; Greenbaum C; Bekris L; Hampe CS; Daniels T; Richter W; Marcovina SM; Rolandsson O; Landin-Olsson M; Kockum I; Lernmark A
    Diabetologia; 2004 Sep; 47(9):1581-91. PubMed ID: 15365614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.
    Kim J; Richter W; Aanstoot HJ; Shi Y; Fu Q; Rajotte R; Warnock G; Baekkeskov S
    Diabetes; 1993 Dec; 42(12):1799-808. PubMed ID: 8243826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.